206 related articles for article (PubMed ID: 25435926)
1. Diagnostic and prognostic serum marker of cholangiocarcinoma (Review).
Zeng X; Tao H
Oncol Lett; 2015 Jan; 9(1):3-8. PubMed ID: 25435926
[TBL] [Abstract][Full Text] [Related]
2. State of serum markers for detection of cholangiocarcinoma.
Wongkham S; Silsirivanit A
Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
[TBL] [Abstract][Full Text] [Related]
3. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
[TBL] [Abstract][Full Text] [Related]
4. Current omics-based biomarkers for cholangiocarcinoma.
Intuyod K; Armartmuntree N; Jusakul A; Sakonsinsiri C; Thanan R; Pinlaor S
Expert Rev Mol Diagn; 2019 Nov; 19(11):997-1005. PubMed ID: 31566016
[No Abstract] [Full Text] [Related]
5. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.
Saentaweesuk W; Silsirivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Pairojkul C; Cha'on U; Indramanee S; Pinlaor S; Boonmars T; Araki N; Wongkham C
Clin Chim Acta; 2018 Feb; 477():66-71. PubMed ID: 29217428
[TBL] [Abstract][Full Text] [Related]
8. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
[TBL] [Abstract][Full Text] [Related]
9. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.
Wang B; Chen L; Chang HT
Biomark Med; 2016 Jun; 10(6):613-9. PubMed ID: 27232281
[TBL] [Abstract][Full Text] [Related]
10. Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.
Thuwajit C; Thuwajit P; Jamjantra P; Pairojkul C; Wongkham S; Bhudhisawasdi V; Ono J; Ohta S; Fujimoto K; Izuhara K
Oncol Lett; 2017 Jul; 14(1):623-634. PubMed ID: 28693214
[TBL] [Abstract][Full Text] [Related]
11. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
[TBL] [Abstract][Full Text] [Related]
12. Next-Generation Biomarkers for Cholangiocarcinoma.
Rodrigues PM; Vogel A; Arrese M; Balderramo DC; Valle JW; Banales JM
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203269
[TBL] [Abstract][Full Text] [Related]
13. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
[TBL] [Abstract][Full Text] [Related]
14. Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.
Janvilisri T; Leelawat K; Roytrakul S; Paemanee A; Tohtong R
Dis Markers; 2015; 2015():105358. PubMed ID: 26060332
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic features of 512 cases of cholangiocarcinoma.
Kuang-Zeng S; Rao L; Luo B; Luo L; Liu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 45(11):1283-1290. PubMed ID: 35753742
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
[TBL] [Abstract][Full Text] [Related]
17. Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance.
Ehlken H; Zenouzi R; Schramm C
Curr Opin Gastroenterol; 2017 Mar; 33(2):78-84. PubMed ID: 28146445
[TBL] [Abstract][Full Text] [Related]
18. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma.
Sanmai S; Proungvitaya T; Limpaiboon T; Chua-On D; Seubwai W; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sangkhamanon S; Proungvitaya S
Oncol Lett; 2019 Jun; 17(6):5275-5282. PubMed ID: 31186744
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area.
Sungkasubun P; Siripongsakun S; Akkarachinorate K; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Singharuksa S; Chanwat R; Bunchaliew C; Charoenphattharaphesat S; Molek R; Yimyaem M; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU; Mahidol C
BMC Cancer; 2016 Jun; 16():346. PubMed ID: 27251649
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms.
Kimawaha P; Jusakul A; Junsawang P; Thanan R; Titapun A; Khuntikeo N; Techasen A
Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33806004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
